The enduring success of Viagra has undeniably shaped the healthcare landscape. However, investing in companies heavily focused on biosimilars and the waning patent exclusivity surrounding this flagship medication presents a considerable degree of danger. While leading pharma firms can still profi
Viagra, Vegas, and Vipers: The Next Bitcoin?
The digital asset space is known for its unpredictable nature. This week, the latest trend seems to be a pump-and-dump scheme dubbed "Viagra, Vegas, and Vipers." This currency has skyrocketed in value, fueled by hype about its potential to transform the market landscape. Some investors are bullis